Medeon Biodesign, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 94.592 million compared to TWD 468.147 million a year ago. Operating loss was TWD 60.643 million compared to operating income of TWD 357.284 million a year ago. Net loss was TWD 52.724 million compared to net income of TWD 373.112 million a year ago. Basic loss per share was TWD 0.9 compared to basic earnings per share of TWD 7.19 a year ago. Diluted loss per share was TWD 0.9 compared to diluted earnings per share of TWD 7.1 a year ago.